Splenectomy has a limited role in the management of lupus with thrombocytopenia

Journal of Rheumatology

Volumn 29, Issue 1, 2002, Pages 1-2

  Alarcon Segovia D ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

DANAZOL; HYDROXYCHLOROQUINE; PREDNISONE;

CLINICAL TRIAL; EDITORIAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; LUPUS ERYTHEMATOSUS; PRIORITY JOURNAL; REMISSION; SPLENECTOMY; THROMBOCYTOPENIA; THROMBOCYTOPENIC PURPURA; TREATMENT INDICATION; VASCULITIS;

FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; PATIENT SELECTION; SPLENECTOMY; THROMBOCYTOPENIA;

EID: 0036139805     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (8)

1. Hemolytic anemia and thrombocytopenic purpura: Two related subsets of systemic lupus erythematosus
2. Occurrence of both hemolytic anemia and thrombocytopenic purpura (Evans' syndrome) in systemic lupus erythematosus. Relationship to antiphospholipid antibodies
3. Systemic lupus erythematosus. Differences between patients who do, and who do not, fulfill classification criteria at the time of diagnosis
4. Treatment of severe immune thrombocytopenia associated with systemic lupus erythematosus: A report of 59 cases
5. Splenectomy and subsequent mortality in veterans of the 1939-45 war
6. Exacerbation of lupus erythematosus following splenectomy in "idiopathic" thrombocytopenic purpura and autoimmune hemolytic anemia
7. Splenectomy does not cure the thrombocytopenia of systemic lupus erythematosus
8. Splenectomy for hemocytopenia in systemic lupus erythematosus. A controlled appraisal